Innate immune-mediated control of pulmonary Legionella pneumophila infection
先天免疫介导控制肺部嗜肺军团菌感染
基本信息
- 批准号:9180679
- 负责人:
- 金额:$ 40万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2015
- 资助国家:美国
- 起止时间:2015-11-16 至 2020-10-31
- 项目状态:已结题
- 来源:
- 关键词:AIDS VaccinesAlveolar MacrophagesAnti-Bacterial AgentsAntibiotic ResistanceBacterial InfectionsCellsCommunitiesCommunity HospitalsDataDefense MechanismsDevelopmentEnsureEpithelial CellsEpitheliumFamilyFutureGeneticHost DefenseHost Defense MechanismImmuneImmune responseImmune signalingImmunityIn VitroIndividualInfectionInfection ControlInflammatoryInflammatory ResponseInjectableInnate Immune SystemInterleukin-1Interleukin-1 alphaInterleukin-1 betaInterleukin-12Interleukin-18Interleukin-6KnowledgeLegionellaLegionella pneumophilaLegionnaires&apos DiseaseLungMediatingMolecularMorbidity - disease rateMusNeutrophil InfiltrationNosocomial pneumoniaOutcomePathway interactionsPneumoniaProductionProtein BiosynthesisProteinsPublishingResearchRoleSignal TransductionTNF geneTestingTherapeuticToll-like receptorsType IV Secretion System PathwayVaccine DesignVaccinesVirulenceVirulence Factorsalveolar epitheliumantimicrobialbasecell typechemokinecytokinedesignimmune clearanceimmune functionimprovedinsightinterleukin-18 receptormicrobialmortalitymouse modelneutrophilnovelnovel strategiesparacrinepathogenpublic health relevancerelease factorresponse
项目摘要
DESCRIPTION (provided by applicant): Clearance of intracellular bacterial pathogens requires initiation of an effective immune response. However, pathogens have evolved virulence factors to disable such immune responses. A key gap in our knowledge is to understand how successful host defense can be achieved despite pathogen subversion. Legionella pneumophila, an important cause of community- and hospital-acquired pneumonia, disarms and replicates within alveolar macrophages by delivering bacterial effectors via a type IV secretion system (T4SS). Several T4SS effectors potently block host protein synthesis. However, host sensing of Legionella T4SS-translocated substrates paradoxically enhances cytokine production. To elucidate the molecular and cellular basis of this host response, we developed a powerful approach to simultaneously track bacterial effector translocation and cytokine responses at the single cell level. We found that infected cells poorly produced several key cytokines, but could still synthesize and release IL-1 family cytokines. Moreover, IL-1 signaling was required for robust production of cytokines by uninfected immune cells and neutrophil-attracting chemokines by lung epithelial cells. Our findings indicate that paracrine IL-1 signaling
circumvents the pathogen-imposed translational block to orchestrate a rapid immune response by uninfected bystander cells. While IL-1 signaling is critical for the initiation of host defense,the cell types responding to IL-1 and the specific consequences of IL-1α and IL-1β responses in these cells are unclear. Moreover, mice lacking IL-1 signaling eventually recover bystander cytokine responses, neutrophil recruitment, and control over infection, suggesting that IL-1-independent immune signals coordinate an additional layer of host defense. Thus, we propose the following Aims to define how IL-1-dependent and IL-1-independent immune mechanisms collaborate to generate successful immunity. In Aim 1, we will test the hypothesis that IL-1α and IL-1β regulate distinct immune functions in different cell types. In Aim 2, we will test the hypothesis that additional IL-1-independent immune signals ensure bystander cytokine production and neutrophil recruitment at later stages of Legionella infection. Together, these studies will define novel innate immune mechanisms employed by the host to surmount pathogen-encoded virulence activities. The proposed research will therefore provide vital insight into mechanisms of host defense that are utilized against broad classes of microbial pathogens and aid development of improved anti-microbial therapeutics and vaccines.
描述(适用提供):细胞内细菌病原体的清除率需要有效的免疫响应。然而,病原体已经进化了病毒因子以禁用这种免疫响应。我们知识上的一个关键差距是了解如何成功实现宿主防御。肺炎军团菌是社区和医院获得的肺炎的重要原因,通过通过IV型分泌系统(T4SS)传递细菌效应子,在肺泡巨噬细胞中解除武装和复制。几种T4SSSSSSSSS可能会阻止宿主蛋白质合成。然而,宿主T4SS转移的底物的宿主传感矛盾地增强了细胞因子的产生。为了阐明该宿主反应的分子和细胞基础,我们开发了一种强大的方法,可以简单地在单细胞水平跟踪细菌效应子易位和细胞因子反应。我们发现感染细胞产生的细胞不足,但仍可以合成并释放IL-1家族细胞因子。此外,未感染的免疫细胞和肺上皮细胞吸引嗜中性粒细胞趋化因子需要IL-1信号传导才能强化细胞因子。我们的发现表明旁分泌IL-1信号传导
绕过病原体施加的翻译阻滞,以协调未感染的旁观者细胞快速免疫响应。尽管IL-1信号对于宿主防御的倡议至关重要,但对IL-1响应的细胞类型以及这些细胞中IL-1α和IL-1β反应的特定后果尚不清楚。此外,缺乏IL-1信号传导的小鼠最终恢复了旁观者的细胞因子反应,中性粒细胞的募集以及对感染的控制,这表明IL-1非依赖性免疫信号协调了额外的宿主防御层。这就是我们提出以下旨在定义IL-1依赖性和IL-1独立的免疫机制如何协作以生成成功的免疫组织化学物质。在AIM 1中,我们将检验以下假设:IL-1α和IL-1β调节不同细胞类型中不同的免疫素功能。在AIM 2中,我们将检验以下假设:额外的IL-1非依赖性免疫信号可确保在军团菌感染的后期旁观者细胞因子的产生和中性粒细胞募集。总之,这些研究将定义宿主采用的新的先天免疫力学来克服病原体编码的病毒活性。因此,拟议的研究将提供对宿主防御机制的重要见解,宿主防御机制可用于针对广泛的微生物病原体,并有助于开发改善的抗微生物治疗和疫苗。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Sunny Shin其他文献
Sunny Shin的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Sunny Shin', 18)}}的其他基金
Effector-triggered immunity against Legionella pneumophila in dendritic cells
树突状细胞中针对嗜肺军团菌的效应子触发免疫
- 批准号:
10753211 - 财政年份:2023
- 资助金额:
$ 40万 - 项目类别:
TNF and caspase-8-mediated control of Legionella pneumophila infection
TNF 和 caspase-8 介导的嗜肺军团菌感染控制
- 批准号:
10364637 - 财政年份:2021
- 资助金额:
$ 40万 - 项目类别:
Defining human noncanonical inflammasome responses to Legionella pneumophila
定义人类对嗜肺军团菌的非典型炎症反应
- 批准号:
9214308 - 财政年份:2016
- 资助金额:
$ 40万 - 项目类别:
Defining human noncanonical inflammasome responses to Legionella pneumophila
定义人类对嗜肺军团菌的非典型炎症反应
- 批准号:
9079707 - 财政年份:2016
- 资助金额:
$ 40万 - 项目类别:
Innate immune-mediated control of pulmonary Legionella pneumophila infection
先天免疫介导控制肺部嗜肺军团菌感染
- 批准号:
10867793 - 财政年份:2015
- 资助金额:
$ 40万 - 项目类别:
Innate immune-mediated control of pulmonary Legionella pneumophila infection
先天免疫介导控制肺部嗜肺军团菌感染
- 批准号:
10675707 - 财政年份:2015
- 资助金额:
$ 40万 - 项目类别:
Innate immune-mediated control of pulmonary Legionella pneumophila infection
先天免疫介导控制肺部嗜肺军团菌感染
- 批准号:
9378776 - 财政年份:2015
- 资助金额:
$ 40万 - 项目类别:
Innate immune-mediated control of pulmonary Legionella pneumophila infection
先天免疫介导控制肺部嗜肺军团菌感染
- 批准号:
9052504 - 财政年份:2015
- 资助金额:
$ 40万 - 项目类别:
Innate immune-mediated control of pulmonary Legionella pneumophila infection
先天免疫介导控制肺部嗜肺军团菌感染
- 批准号:
10317640 - 财政年份:2015
- 资助金额:
$ 40万 - 项目类别:
Innate immune-mediated control of pulmonary Legionella pneumophila infection
先天免疫介导控制肺部嗜肺军团菌感染
- 批准号:
10437007 - 财政年份:2015
- 资助金额:
$ 40万 - 项目类别:
相似国自然基金
丙酮酸羧化酶乳酸化修饰介导TCA回补途径调控肺泡巨噬细胞极化在脓毒症ARDS中的机制研究
- 批准号:82300100
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
骨肉瘤细胞通过分泌蛋白SMOC1诱导肺泡巨噬细胞极化促进其肺转移的作用及其机制
- 批准号:82373026
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
肺泡巨噬细胞嘌呤代谢紊乱介导重症肺炎发病的作用机制研究
- 批准号:82370010
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
新冠病毒N蛋白通过结合RAGE以促进肺泡巨噬细胞内质网-线粒体接触位点(MAM)的形成而诱导急性肺损伤的机制研究
- 批准号:82370080
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
铜绿假单胞菌分泌蛋白PA3125通过诱导肺泡巨噬细胞PKM2甲基化修饰抑制抗原提呈的机制研究
- 批准号:82370014
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
相似海外基金
Combinatorial cytokine-coated macrophages for targeted immunomodulation in acute lung injury
组合细胞因子包被的巨噬细胞用于急性肺损伤的靶向免疫调节
- 批准号:
10648387 - 财政年份:2023
- 资助金额:
$ 40万 - 项目类别:
Investigating the Contribution of the Coxiella Cell Wall to Intracellular Pathogenesis
研究柯克斯体细胞壁对细胞内发病机制的贡献
- 批准号:
10593290 - 财政年份:2023
- 资助金额:
$ 40万 - 项目类别:
Airway Prevotella enhance innate immune-mediated protection against lung infection
气道普雷沃氏菌增强先天免疫介导的肺部感染保护
- 批准号:
10561450 - 财政年份:2023
- 资助金额:
$ 40万 - 项目类别:
Biomimetic Macrophage Membrane-Coated Nanosponges: A Novel Therapeutic for Multidrug-Resistant Pseudomonas aeruginosa and Acinetobacter baumannii Hospital-Associated Pneumonia
仿生巨噬细胞膜包被的纳米海绵:一种治疗多重耐药铜绿假单胞菌和鲍曼不动杆菌医院相关肺炎的新疗法
- 批准号:
10674406 - 财政年份:2023
- 资助金额:
$ 40万 - 项目类别: